Alzamend Neuro, Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureSep 29 →Insiders1 insider bought $108,388 in 1 open-market buy. 3 insiders sold $448,562, 0 of 6 sales on a 10b5-1 plan.→HoldersKMT Wealth 27.5%Kingsbury Capital Investment 27.5%Geode 0.5%→Financing →PeersClosest companies: KTTA, ARTL, PLYX→
From the filings
Figures
- Net income
- −$9.1Mlast 12 months
- Operating cash flow
- −$6.8Mlast 12 months
- Cash and equivalents
- $7.6Mat the last balance sheet
- Shares outstanding
- 4.8M shareson issue